2014 annual financial data
Seres Therapeutics 2014 Operating margin
Seres Therapeutics 2014 operating margin with verified reported values.
Direct answer
Operating margin was Not calculable.
Operating income was -15,082,000 USD and net income was -16,709,000 USD.
Operating cash flow was -10,358,000 USD.
Get free Seres Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 0 USD
- Operating income
- -15,082,000 USD
- Net income
- -16,709,000 USD
- Operating cash flow
- -10,358,000 USD